A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin
Tuberculosis (TB) subunit vaccines have been investigated as boosters for BCG-induced immunity. Here, the authors design a TB subunit vaccine that doesn't share antigens with BCG and show that co-administration of the two vaccines broadens the T cell response to TB and increases protection.
Saved in:
Main Authors: | Joshua S. Woodworth, Helena Strand Clemmensen, Hannah Battey, Karin Dijkman, Thomas Lindenstrøm, Raquel Salvador Laureano, Randy Taplitz, Jeffrey Morgan, Claus Aagaard, Ida Rosenkrands, Cecilia S. Lindestam Arlehamn, Peter Andersen, Rasmus Mortensen |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e8cde506edf04ab4beac2a4d5130dcb7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine
by: Helen A. Fletcher
Published: (2016) -
An ambivalent prostate nodule after Bacillus Calmette-Guérin therapy
by: L. Sauvat, et al.
Published: (2021) -
The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
by: Junli Li, et al.
Published: (2021) -
An Interesting Similarity of Bacillus Calmette-Guerin and Chimeric Antigen Receptor T Cells
by: Seyed Saeed Tamehri Zadeh, et al.
Published: (2020) -
<i>In Vivo</i>
Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection
by: Helena Strand Clemmensen, et al.
Published: (2021)